Reaction
Chronic Rhinosinusitis With Nasal Polyps reporting signals
As of the last recalculation, Chronic Rhinosinusitis With Nasal Polyps appears in 139 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is BENRALIZUMAB (PRR 38.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Benralizumab | 5 | 38.8 | 38.8 |
| Dupilumab | 65 | 37.1 | 37.1 |